Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 509

1.

Enhanced astrocytic d-serine underlies synaptic damage after traumatic brain injury.

Perez EJ, Tapanes SA, Loris ZB, Balu DT, Sick TJ, Coyle JT, Liebl DJ.

J Clin Invest. 2017 Jul 17. pii: 92300. doi: 10.1172/JCI92300. [Epub ahead of print]

2.

Schizophrenia: Basic and Clinical.

Coyle JT.

Adv Neurobiol. 2017;15:255-280. doi: 10.1007/978-3-319-57193-5_9.

PMID:
28674984
3.

Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Noh H, Shao Z, Coyle JT, Chung S.

Biochim Biophys Acta. 2017 Jun 28;1863(9):2382-2387. doi: 10.1016/j.bbadis.2017.06.019. [Epub ahead of print] Review.

PMID:
28668333
4.

Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic Schizophrenia.

Coyle JT.

Am J Psychiatry. 2017 Jun 1;174(6):510-511. doi: 10.1176/appi.ajp.2017.17030318. No abstract available.

PMID:
28565949
5.

Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.

Tobe BTD, Crain AM, Winquist AM, Calabrese B, Makihara H, Zhao WN, Lalonde J, Nakamura H, Konopaske G, Sidor M, Pernia CD, Yamashita N, Wada M, Inoue Y, Nakamura F, Sheridan SD, Logan RW, Brandel M, Wu D, Hunsberger J, Dorsett L, Duerr C, Basa RCB, McCarthy MJ, Udeshi ND, Mertins P, Carr SA, Rouleau GA, Mastrangelo L, Li J, Gutierrez GJ, Brill LM, Venizelos N, Chen G, Nye JS, Manji H, Price JH, McClung CA, Akiskal HS, Alda M, Chuang DM, Coyle JT, Liu Y, Teng YD, Ohshima T, Mikoshiba K, Sidman RL, Halpain S, Haggarty SJ, Goshima Y, Snyder EY.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4462-E4471. doi: 10.1073/pnas.1700111114. Epub 2017 May 12.

6.

The Rise and Fall of the d-Serine-Mediated Gliotransmission Hypothesis.

Wolosker H, Balu DT, Coyle JT.

Trends Neurosci. 2016 Nov;39(11):712-721. doi: 10.1016/j.tins.2016.09.007. Epub 2016 Oct 11. Review.

PMID:
27742076
7.

Endogenous co-agonists of the NMDA receptor modulate contextual fear in trace conditioning.

Basu AC, Puhl MD, Coyle JT.

Neurobiol Learn Mem. 2016 Dec;136:244-250. doi: 10.1016/j.nlm.2016.09.006. Epub 2016 Sep 12.

PMID:
27633914
8.

EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain.

Perez EJ, Cepero ML, Perez SU, Coyle JT, Sick TJ, Liebl DJ.

Neurobiol Dis. 2016 Oct;94:73-84. doi: 10.1016/j.nbd.2016.06.007. Epub 2016 Jun 16.

9.

Glutamatergic Dysfunction in Schizophrenia Evaluated With Magnetic Resonance Spectroscopy.

Coyle JT, Konopaske G.

JAMA Psychiatry. 2016 Jul 1;73(7):649-50. doi: 10.1001/jamapsychiatry.2016.0575. No abstract available.

PMID:
27305626
10.

My Life in Clinical Neuroscience: The Beginning.

Coyle JT.

Adv Pharmacol. 2016;76:1-12. doi: 10.1016/bs.apha.2016.02.002. Epub 2016 Mar 24.

PMID:
27288071
11.

History of the Concept of Disconnectivity in Schizophrenia.

Coyle JT, Balu DT, Puhl MD, Konopaske GT.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):80-6. doi: 10.1097/HRP.0000000000000102. Review.

12.

Touchscreen assays of learning, response inhibition, and motivation in the marmoset (Callithrix jacchus).

Kangas BD, Bergman J, Coyle JT.

Anim Cogn. 2016 May;19(3):673-7. doi: 10.1007/s10071-016-0959-4. Epub 2016 Feb 3.

13.

An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.

Balu DT, Li Y, Takagi S, Presti KT, Ramikie TS, Rook JM, Jones CK, Lindsley CW, Conn PJ, Bolshakov VY, Coyle JT.

Neuropsychopharmacology. 2016 Jul;41(8):2052-61. doi: 10.1038/npp.2016.2. Epub 2016 Jan 7.

14.

[JSNP Excellent Presentation Award for CINP2014].

Ishiwata S, Balu DT, Umino A, Coyle JT, Nishikawa T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2015 Apr;35(2):53-4. Japanese. No abstract available.

PMID:
26027070
15.

Possible compensatory mechanisms for glutamatergic disconnection found in the auditory cortex in schizophrenia.

Konopaske GT, Coyle JT.

Biol Psychiatry. 2015 Jun 1;77(11):923-4. doi: 10.1016/j.biopsych.2015.03.031. No abstract available.

16.
17.

Neuronal serine racemase regulates extracellular D-serine levels in the adult mouse hippocampus.

Ishiwata S, Umino A, Balu DT, Coyle JT, Nishikawa T.

J Neural Transm (Vienna). 2015 Aug;122(8):1099-103. doi: 10.1007/s00702-015-1388-2. Epub 2015 Mar 18.

18.

Altered prefrontal cortical MARCKS and PPP1R9A mRNA expression in schizophrenia and bipolar disorder.

Konopaske GT, Subburaju S, Coyle JT, Benes FM.

Schizophr Res. 2015 May;164(1-3):100-8. doi: 10.1016/j.schres.2015.02.005. Epub 2015 Mar 7.

19.

Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.

Takagi S, Balu DT, Coyle JT.

Schizophr Res. 2015 Mar;162(1-3):216-21. doi: 10.1016/j.schres.2014.12.034. Epub 2015 Jan 12.

20.

The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.

Balu DT, Coyle JT.

Curr Opin Pharmacol. 2015 Feb;20:109-15. doi: 10.1016/j.coph.2014.12.004. Epub 2014 Dec 23. Review.

Supplemental Content

Loading ...
Support Center